Starting October 1st, the Saskatchewan government will provide coverage for the cystic fibrosis medication Trikafta. The drug has been shown to improve the quality of life for patients.  

"Trikafta is the single greatest innovation in cystic fibrosis history and it has the power to transform the lives of thousands of Canadians," Cystic Fibrosis Canada Director of Government and Community Relations Kim Steele said. "The CF community in Saskatchewan has fought long and hard to get this drug into their hands. Access to Trikafta will mean longer and healthier lives for so many people, and the ability to plan for a future that many feared they might not live to see." 

The medication has been approved by Health Canada for cystic fibrosis patients 12 years of age and older, with a specific cystic fibrosis mutation. More information about the listing and coverage criteria will be made available by the provincial government in the coming days, and CF patients and their families are encouraged to talk to their doctor about coverage once it is officially listed on the formulary.